Last quarter (Q4 2022), Takeda Pharmaceutical Company's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Takeda Pharmaceutical Company's net income was $―. See Takeda Pharmaceutical Company’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	$ 3.07T	$ 4.03T	$ 3.57T	$ 3.20T	$ 3.29T	$ 2.10T
Cost of Revenue	$ 934.30B	$ 1.41T	$ 1.11T	$ 994.31B	$ 1.09T	$ 651.73B
Gross Profit	$ 2.14T	$ 2.61T	$ 2.46T	$ 2.20T	$ 2.20T	$ 1.45T
Operating Expense	$ 1.74T	$ 2.32T	$ 2.21T	$ 1.87T	$ 1.93T	$ 1.26T
Operating Income	$ 401.94B	$ 295.38B	$ 251.12B	$ 338.31B	$ 274.71B	$ 186.54B
Net Non Operating Interest Income Expense	$ -71.64B	$ 62.91B	$ 23.70B	$ -137.85B	$ -146.65B	$ -60.96B
Other Income Expense	$ -3.13B	$ -333.81B	$ -27.76B	$ 165.77B	$ -188.81B	$ 2.03B
Pretax Income	$ 327.18B	$ 692.11B	$ 532.63B	$ 366.24B	$ -60.75B	$ 127.61B
Tax Provision	$ 41.27B	$ 58.05B	$ 72.41B	$ -9.94B	$ -105.04B	$ -7.47B
Earnings From Equity Interest Net Of Tax	-	$ -8.63B	$ -15.37B	-	-	-
Net Income Common Stockholders	$ 285.88B	$ 634.08B	$ 460.33B	$ 376.00B	$ 44.24B	$ 135.19B
Basic EPS	$ 92.16	$ 204.29	$ 147.14	$ 120.36	$ 14.21	$ 56.75
Diluted EPS	$ 91.33	$ 201.94	$ 145.87	$ 119.48	$ 14.13	$ 56.43
Basic Average Shares	$ 9.34B	$ 1.55B	$ 1.56B	$ 3.12B	$ 3.13B	$ 1.92B
Diluted Average Shares	$ 9.40B	$ 1.55B	$ 1.56B	$ 3.15B	$ 3.13B	$ 1.93B
Dividend Per Share	-	-	-	$ 90.35	$ 89.67	$ 91.22
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	$ 72.50	-	-	$ 210.00	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 2.67T	$ 3.73T	$ 3.32T	$ 2.86T	$ 3.02T	$ 1.91T
Net Income From Continuing And Discontinued Operation	$ 285.88B	$ 634.08B	$ 460.33B	$ 376.00B	$ 44.24B	$ 135.19B
Normalized Income	$ 285.88B	-	-	$ 261.05B	$ 158.60B	$ 103.52B
Interest Expense	$ 189.02B	-	-	$ 130.81B	$ 149.01B	$ 48.16B
EBIT	$ 516.20B	$ 575.13B	$ 410.20B	$ 497.04B	$ 88.26B	$ 175.77B
EBITDA	$ 1.02T	$ 1.24T	$ 993.35B	$ 1.06T	$ 671.90B	$ 423.46B

Currency in USD

Takeda Pharmaceutical Company Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing